Professor of Molecular Biology at the Department of Biochemistry of the Faculty of Medicine, Director of research at the Cell Therapy Centre, and Head of the Molecular Diagnostics Lab at the University of Jordan Hospital, Dr. Said Ismail earned his BSc degree in Medical Laboratories Technology from the University of Jordan in 1995, MSc degree in Applied Molecular Biology and Biotechnology form University College London in 1996, and PhD in Biochemistry form University of Oxford in 2000.
Dr. Ismail spent two years as a Research Fellow at the Ludwig Cancer Institute of the University College London before joining the University of Jordan as an assistant professor in 2002, where he was promoted to associate professor in 2008 and professor in 2013.
Dr. Ismail is a highly accomplished scholar with numerous published research articles in international peer reviewed journals, and has supervised the research work of tens of graduate students. He also received several scientific research grants and co-owns a patent on “Aptamers as JAK2 kinase inhibitors.” He is the co-winner of the 2013 Abdul Hameed Shoman Award for Arab Researchers in Medical and Health Sciences (Cancer and Cancer Stem Cells).
He is a Scientific Consultant for Aragen Biotechnology, Amman-Jordan, and a member of the editorial board for the Journal of Molecular and Genetic Medicine. He is also a member of the Jordan Advisory Board of the International Consortium for the American Society for Clinical Pathology International (ASCPi), and previously held the position of Vice President of the Jordanian Genes Society (2005). Dr. Ismail also chaired the First Oxford Symposium on Aptamers which was held 24-25 March 2014.
The symposium was one of the first international meetings at Oxford that brought together the aptamer community from both academia and industry, and laid the foundations for an annual gathering that would witness the aptamer technology coming of age.